Declare that Hydroxychloroquine Sulfate Tablets 100, 300, and 400 mg, are Suitable for Submission in an Abbreviated New Drug Application (ANDA); CLOSED
🏛 Food and Drug Administration (FDA)FDA-2013-P-0170
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Mar 1, 2013No comment period